NYSE:TARO - Taro Pharmaceutical Industries Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$105.15 +0.72 (+0.69 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$104.43
Today's Range$103.4950 - $105.37
52-Week Range$76.93 - $121.23
Volume64,087 shs
Average Volume67,122 shs
Market Capitalization$4.15 billion
P/E Ratio17.01
Dividend YieldN/A
Beta0.54

Analyst Ratings

Taro Pharmaceutical Industries (NYSE:TARO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Taro Pharmaceutical Industries in the last 12 months. Their average twelve-month price target is $115.00, suggesting that the stock has a possible upside of 9.37%. The high price target for TARO is $115.00 and the low price target for TARO is $115.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $115.00$115.00$120.00$120.00
Price Target Upside: 9.37% upside13.74% upside22.08% upside6.44% upside

Taro Pharmaceutical Industries (NYSE:TARO) Consensus Price Target History

Price Target History for Taro Pharmaceutical Industries (NYSE:TARO)

Taro Pharmaceutical Industries (NYSE:TARO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/10/2018HC WainwrightReiterated RatingBuy$115.00LowView Rating Details
5/23/2017Credit Suisse GroupDowngradeOutperform ➝ NeutralLowView Rating Details
(Data available from 2/18/2017 forward)
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel